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CLINICAL EXPERIENCE IN DENGUE: EXPERIENCE OF SPECIALIZED SERVICE
Luiz José de SOUZA(1) & Marcos BOULOS(2)
Although known for centuries, the infection by dengue virus is 
starting to exhibit different and more exuberant manifestations from 
the previously known forms from the middle of last century with the 
description of the hemorrhagic form of the disease.
The World Health Organization, aiming to standardize the different 
manifestations of dengue fever, has proposed a classification that would 
not only standardize the information, but mainly suggest actions to reduce 
the risk of death by this disease.
Despite the importance and need for guidance on the different clinical 
forms and procedures to be instituted, new manifestations, unexpected 
and expected, of dengue began to emerge with the spread of disease.
Different studies have pointed to regional differences regarding the 
clinical manifestations due to not only the prevalent serotype, but also 
the genetic polymorphism that can provide protection and also induce 
more severe forms of disease8.
The pattern of dengue prevalence among children, so common in 
regions where this disease is endemic for a long time, began to emerge in 
the Brazilian population in places where infection has occurred annually.
We present here the experience from a healthcare center providing 
assistance to patients with dengue in Brazil, which demonstrates the 
data exposed above.
The Reference Center of Dengue (Centro de Referência da Dengue, 
CRD), located in the city of Campos dos Goytacazes, unique in the 
country, is important for the population of this city and neighboring cities 
due to the high incidence of dengue in this region, and also contributing to 
a better understanding of dengue in Brazil and suggesting new approaches 
to provide care to a patient affected by this virus.
In 2010, CRD provided assistance to children which represented 
11.44% of cases of dengue and in 2011, the cases in children up to 14 
years were 14.99% by September. This data indicates worsening of this 
disease in younger children in the near future.
The clinical signs are always initiated by fever, headache, myalgia, 
anorexia, retro-orbital pain, nausea, prostration, vomiting, diarrhea and 
rash in lower percentage. 
In the second or third day after the onset of symptoms, warning signs 
of hemorrhagic dengue appears in severe cases: abdominal pain, severe 
prostration, persistent vomiting and hypotension, which are conditions 
that require more vigorous action by doctors and other healthcare 
professionals. 
These conditions, based on the pathophysiology of the dengue fever, 
occur due to increased vascular permeability with consequent leakage 
of liquids, dehydration, hemoconcentration, conditions which must be 
reversed immediately with intravenous hydration based on crystalloid 
solutions (saline or Lactated Ringer), introduced at high rates on the 
basis of 20mL/kg/h and lower rates in order to stabilize the patient 
during hospitalization.
In the 2010 survey, based on medical records from 206 patients aged 
over 13 years, we observed the presence of serositis (pleural effusion 
and ascitis) in 55 patients, i.e., more than 25% of the hospitalized cases 
of dengue. 
There was a difference in relation to pediatric patients. In adult 
patients with serositis, 95% of the cases were due to secondary infection, 
while children with serositis progressed to shock and death, and this was 
due to the primary form of dengue. 
Importantly, at the time these observations were seen, serotype 2 
infection prevailed in the region, which was pointed by several studies 
as the cause of the most severe forms of dengue.
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Corroborating those studies, this worsening could be detected 
among children followed in this center which is probably due to their 
decreased immunity, what makes imperative the appropriate training and 
management of these patients by pediatricians.
A finding that deserves mention is the presence of thrombocytopenia 
in 50 from 55 patients with serositis. Cases with comorbidity (chronic 
renal failure, heart failure, diabetes or obesity) received platelet 
transfusion, which did not avoid events of bleeding. 
A protocol for diagnosis was standardized with some nonspecific 
tests, such as CBC, erythrocyte sedimentation rate (ESR) and 
transaminases. Our observations suggest that leucopenia and not 
increased or reduced ESR represent indication for dengue diagnosis. 
Based on our observation, reduced ESR is more frequent among the 
more severe forms of the disease. 
Ideally, the NS1 antigen assay should be requested from the 2nd to 
4th day after onset of symptoms. In severe cases, it is very important 
to keep serum collected by the 5th day for determination of C-reactive 
protein (CRP) and assessment of the circulating serotype in cases of 
deaths. 
Serology (antibody measurement) should be only made after the 8th 
day of onset of symptoms. 
It is important to highlight that atypical clinical manifestations of 
dengue have been found, such as: involvement of the nervous system, 
heart conditions, peripheral neuropathies, purpura, ascitis, acute abdomen 
and liver abnormalities.
Liver abnormalities are quite frequent with high levels and the 
dosage of aminotransferases has been an important prognostic factor in 
our observations.
The Reference Center of Dengue (CRD) is important not only in the 
diagnosis and treatment of patients, but also in the assistance to combat 
the vector. 
The following are positive points for CRD: 
1. Centralization of information with improved notification. 
2. Early notification for the department in charge to control vector. 
3. Continuing epidemiological surveillance. 
4. Early and accurate diagnosis. 
5. Patients are monitored and thus, deaths are avoided. 
The organization of care is paramount to achieve better results in the 
management of patients with dengue bringing efficiency in the differential 
diagnosis, which is quite broad.
The poor infrastructure for vector control primarily due to: low 
synchrony between cities, high rate of vectorial movement, unstructured 
and anarchic urban centers, underreporting of cases, errors in diagnosis, 
poor basic sanitation, lack of urban planning, inadequate management 
of solid waste (garbage), deterioration of public health infrastructure, 
leads to the consequent absence of proper control of the mosquito and 
non-eradication of outbreak foci. 
Other social factors, such as unemployment, violence and educational 
deficiency, common in the country as a whole with special emphasis 
in the area we work are obviously associated with the difficulties of 
controlling dengue in our area.
Although the studies with vaccines protecting against all four 
serotypes are in advanced stages, which may represent an important 
measure to reduce dengue and risks arising from it, it could probably 
take several years to be used.
The circulation of the four serotypes (1, 2, 3 and 4) and the 
reintroduction of these serotypes, in different states of our country, 
indicate that the mortality by dengue fever is expected to increase, 
representing a real risk to public health in Brazil.
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In summary, the actions taken at CRD allowed not only to provide 
quality action to assist people with dengue fever, but also to propose 
simple laboratory markers to predict cases with more severe progression 
of the disease, especially in children.
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